Summer peaks in uptake of human papillomavirus and other adolescent vaccines in the United States

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 2, 2016, Pages 274-281

  Moss, Jennifer L ^a   Reiter, Paul L ^b   Rimer, Barbara K ^a,c   Ribisl, Kurt M ^a,c   Brewer, Noel T ^a,c  

^a University of North Carolina at Chapel Hill   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; FEMALE; HUMAN; MALE; SEASON; UNITED STATES;

ADOLESCENT; FEMALE; HUMANS; MALE; PAPILLOMAVIRUS VACCINES; SEASONS; UNITED STATES;

EID: 84957800358     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0574     Document Type: Article

References (37)

1. Centers for Disease Control and Prevention (CDC). Recommendations and guidelines: Advisory Committee on Immunization Practices; 2015. Available from: http://www.cdc.gov/vaccines/acip/index.html.
2. Elam-Evans LD, Yankey D, Jeyarajah J, Singleton JA, Curtis RC, MacNeil J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2013. MMWR Morb Mortal Wkly Rep 2014;63:625-33.
3. Department of Health and Human Services. Immunization and infectious diseases; 2015. Available from: http://healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId23.
4. Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13-17 years-United States, 2012. MMWR Morb Mortal Wkly Rep 2013;62:685-93.
5. President's Cancer Panel. Accelerating HPV vaccine uptake: Urgency for action to prevent cancer. Available fromhttp://deainfo.nci.nih.gov/advisory/pcp/annualReports/HPV/PDF/PCP-Annual-Report-2012-2013.pdf. Updated 2014.
6. Centers for Disease Control and Prevention (CDC). HPV vaccine: Safe, effective, and grossly underutilized; 2013. Available from: http://www.cdc.gov/media/releases/2013/p0725-HPV-vaccine.html.
7. Noronha AS, Markowitz LE, Dunne EF. Systematic review of human papillomavirus vaccine coadministration. Vaccine 2014;32:2670-4.
8. Arguedas A, Soley C, Loaiza C, Rincon G, Guevara S, Perez A, et al. Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with tdap and HPV vaccines. Vaccine 2010;28:3171-9.
9. Reisinger KS, Block SL, Collins-Ogle M, Marchant C, Catlett M, Radley D, et al. Safety, tolerability, and immunogenicity of Gardasil given concomitantly with Menactra and Adacel. Pediatrics 2010;125:1142-51.
10. Wheeler CM, Harvey BM, Pichichero ME, Simon MW, Combs SP, Blatter MM, et al. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trial. Pediatr Infect Dis J 2011;30:e225-34.
11. Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, et al. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014-United States. MMWR Morb Mortal Wkly Rep 2014;63:620-4.
12. Laugesen MJ, Mistry R, Carameli KA, Ribisl KM, Needleman J, Bastani R. Early policy responses to the human papillomavirus vaccine in the United States, 2006-2010. J Adolesc Health 2014;55:659-64.
13. Immunization Action Coalition. State information: State mandates on immunization and vaccine-preventable diseases; 2015. Available fromhttp://www.immunize.org/laws.
14. Sull M, Eavey J, Papadouka V, Mandell R, Hansen MA, Zucker JR. Adolescent vaccine co-administration and coverage in New York City: 2007- 2013. Pediatrics 2014;134:e1576-83.
15. Cullen KA, Stokley S, Markowitz LE. Uptake of human papillomavirus vaccine among adolescent males and females: immunization information system sentinel sites, 2009-2012. Acad Pediatr 2014;14:497-504.
16. Gilkey MB, Dayton AM, Moss JL, Sparks AC, Grimshaw AH, Bowling JM, et al. Increasing provision of adolescent vaccines in primary care: a randomized controlled trial. Pediatrics 2014;134:e346-53.
17. Moss JL, Reiter PL, Dayton A, Brewer NT. Increasing adolescent immunization by webinar: a brief provider intervention at federally qualified health centers. Vaccine 2012;30:4960-3.
18. Centers for Disease Control and Prevention (CDC). National Immunization Survey: Datasets for the National Immunization Survey-Teen; 2015. Available from: http://www.cdc.gov/nchs/nis/data-files-teen.htm.
19. Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60:1705-8.
20. Edwards JH. The recognition and estimation of cyclic trends. Ann Hum Genet 1961;25:83-7.
21. Rau R. Measuring seasonality. In:Rau R, editor. Seasonality in human mortality: a demographic approach. Heidelberg, Germany; 2007. p. 39-81.
22. Hakko H. Seasonal variation of suicides and homicides in Finland: With special attention to statistical techniques used in seasonality studies [dissertation]. Oulu, Finland: University of Oulu; 2000.
23. March L. Some researches concerning the factors of mortality. J R Stat Soc 1912;75:505-38.
24. Ahlbom A. Seasonal variations in the incidence of acute myocardial infarction in Stockholm. Scand J Soc Med 1979;7:127-30.
25. Sun J, Guo X, Ma J, Zhang J, Jia C, Xu A. Seasonality of suicide in Shandong China, 1991-2009: associations with gender, age, area and methods of suicide. J Affect Disord 2011;135:258-66.
26. Yamaguchi S, Dunga A, Broadhead RL, Brabin BJ. Epidemiology of measles in Blantyre, Malawi: analyses of passive surveillance data from 1996 to 1998. Epidemiol Infect 2002;129:361-9.
27. Alexander JA, Hearld LR. The science of quality improvement implementation: developing capacity to make a difference. Med Care 2011;49:S6-20.
28. Marshall M, Mountford J. Developing a science of improvement. J R Soc Med 2013;106:45-50.
29. Small SL, Sampselle CM, Martyn KK, Dempsey AF. Modifiable influences on female HPV vaccine uptake at the clinic encounter level: a literature review. J Am Assoc Nurse Pract 2013;26:519-25.
30. Dorell C, Yankey D, Kennedy A, Stokley S. Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: National Immunization Survey-Teen, 2010. Clin Pediatr 2013;52:162-70.
31. Malo TL, Hassani D, Staras SA, Shenkman EA, Giuliano AR, Vadaparampil ST. Do Florida Medicaid providers' barriers to HPV vaccination vary based on VFC program participation? Matern Child Health J 2013;17:609-15.
32. Keating KM, Brewer NT, Gottlieb SL, Liddon N, Ludema C, Smith JS. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. J Adolesc Health 2008;43:S61-S7.
33. Skinner JS, Tiro JA, Champion VL. The health belief model. In: Glanz K, Rimer BK, Viswanath K, editors. Health behavior: Theory, research and practice. 5th ed. San Francisco, CA: Wiley; 2015.
34. Wakefield MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. Lancet 2010;376:1261-71.
35. Warner EJ, Barsky RB. The timing and magnitude of retail store markdowns: evidence from weekends and holidays. Q J Econ 1995;110:321-52.
36. Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2015;64:300-4.
37. Briss PA, Rodewald LE, Hinman AR, Shefer AM, Strikas RA, Bernier RR, et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med 2000;18:97-140.